Clinical Study

An Adult And Adolescent Schizophrenia Study To Evaluate The Effects Of Extended Release Injectable

Posted Date: Jan 28, 2020

  • Investigator: Caleb Adler
  • Specialties: Adolescent Psychiatry/Psychology, Psychiatry/Psychology
  • Type of Study: Drug

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Risperidone Extended-Release Injectable Suspension (TV-46000) for Subcutaneous Use as Maintenance Treatment in Adult and Adolescent Patients with Schizophrenia (The RISE Study – The RIsperidone Subcutaneous Extended-release Study)


13 Through 65 Years, Diagnosis Of Schizophrenia


Adult, Adolescent, Schizophrenia

For More Information:

Karen Tugrul, Bsn, Rn

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.